In Silico ADME/Tox Products Market 2006

Publication Date	June 2006
Publisher	Select Biosciences
Product Type	Report
Pages	180
ISBN Number	not applicable
Product Code	SEL00025

Price

£1,540.00
approximately: $2,250 | €1,688

PDF

PRINT £1,285 ($1,878 | €1,408)

Order above formats by FAX

Summary

In Silico predictive ADME/Tox screening is one of the hottest areas in drug discovery. It is widely perceived that the early screening of chemical entities can significantly reduce the expensive costs associated with late stage failures of drugs due to poor ADME/Tox properties. This market research report from Select Biosciences provides an up-to-date overview and analysis of technology, business, regulatory trends and key product profiles.

In this report Select Biosciences presents an analysis of the In Silico ADME/Tox market landscape. Although, the market is at an embryonic stage of development, the insurgence in the number of companies and products offered to this market clearly reflects significant opportunity.

Furthermore, in this report qualitative and quantitative market analysis of In Silico ADME/Tox products is presented. Also presented is the potential market opportunity, and the various factors that are driving and/or restraining the growth of this market.

Key Highlights of this report:

Overview of the drug discovery process
Regulatory requirements for drug approval
The importance of ADME/Tox screening in drug discovery
Market Drivers and Restraints
Industry Challenges
In Silico ADME/Tox screening product analysis
Quantitative market research
Competitive Factors

Content

Declaration
Research Scope
Research Methodology
Chapter 1. Introduction
- Drug Discovery
- The Drug Discovery Process
- Requirements for Clinical Trials
- Clinical Trials
- Limitations of the Drug Discovery Process
- The Importance of ADME/Tox Screening
- Conventional ADME/Tox Screening
- Early ADME/Tox Screening
- Current ADME/Tox Screening Technologies and Applications
- Introduction to In Silico ADME/Tox Screening
Chapter 2: Market Landscape
- Market Drivers and Restraints
- Industry Challenges
- Proof of Concept
- Product Efficacy and Cost Effectiveness
- U.S. and Western European In Silico ADME/Tox Products Market June 2006
- Competitive Nature
- Effective Application
- Concerns of Potential Drugs Disregarded
Chapter 3: Products
- Commercially Available Products
- List of In Silico ADME/Tox Products I
- List of In Silico ADME/Tox Products II
- List of In Silico ADME/Tox Products III
- List of In Silico ADME/Tox Products IV
- Product Analysis
- TOPKAT - Accelrys
- Tsar - Accelrys
- LigandGel - Accelrys
- ZDOCKpro - Accelrys
- DS MedChem Explorer - Accelrys
- Cerius2Accelrys
- Accord Enterprise Informatics (AEI) - Accelrys
- ACD/LogD Suite and ACD/LogD Sol SuiteACD/Labs
- ACD/LogD Batch and ACD/LogD Sol BatchACD/Labs
- ACD/Structure Design SuiteACD/Labs
- ACD/PhysChem BatchACD/Labs
- acslXtremeAegis Technologies Group
- Metabolite ID SoftwareApplied Biosystems
- AurScopeAureus Pharma
- AurQuestAureus Pharma
- Bio-Loom - BioByte
- CQSAR Package - BioByte
- ClogPBioByte
- U.S. and Western European In Silico ADME/Tox Products Market June 2006
- BatchKiBioKin Limited
- DynafitBioKin Limited
- PlateKi, SteadyFitBioKin Limited
- KnowItAllBio-Rad Laboratories Informatics Division
- Class Pharmer Suite - BioReason
- BioPrintCerep
- MOEChemical Computing Group
- CSLogWSChemSilico
- CSLogD - ChemSilico
- CSLogPChemSilico
- CSpKa - ChemSilico
- CSBBB - ChemSilico
- CSPBChemSilico
- CSGenoTox - ChemSilico
- CSHIAChemSilico
- Chenomx NMR Suite 4.0Chenomx
- Pallas Software FamilyComGenex
- Hazard ExpertCompuDrug
- Hazard Expert ProCompuDrug
- MetabolExpertCompuDrug
- MEXAlertCompuDrug
- pKalcCompuDrug
- TPSACompuDrug
- Rule of 5CompuDrug
- PrologPCompuDrug
- ToxAlertCompudrug
- Cloe PK- Cyprotex
- PC ModelsDaylight Chemical Information Systems, Inc
- HintEduSoft
- Molconn-ZEduSoft
- ZapEduSoft
- HASLEduSoft
- MDL QSARElsevier-MDL
- MDL Toxicity DatabaseElsevier-MDL
- U.S. and Western European In Silico ADME/Tox Products Market June 2006
- MDL MetaboliteElsevier-MDL
- MDL SculptElsevier-MDL
- MDL ISIS for ExcelElsevier-MDL
- MDL Carcinogenicity ModuleElsevier-MDL
- RTECSElsevier-MDL
- PhysioLab TehcnologyEntelos
- Equbits ForesightEqubits
- EVOProfileEvotec OAI
- Safe-HitExonhit Therapeutics
- ToxExpress SystemGene Logic
- BioExpress SystemGene Logic
- MetaCoreGeneGo
- MetaDrugGeneGo
- SimPhenyGenomatica
- NONMEMGlobomax Icon
- PDx-PopGlobomax Icon
- PDx-IVIVCGlobomax Icon
- ChemTreeGolden Helix
- HelixTreeGolden Helix
- DrugMatrixIconix Pharmaceuticals
- ActivityBaseIDBS
- BioBookIDBS
- ChemXtraIDBS
- PredictionBaseIDBS
- GalileoInnaPhase
- WatsonInnaPhase
- NewtonInnaPhase
- KineticaInnaPhase
- DrugMEtJurilab
- ToxMLLeadScope
- LeadScope Toxicity DatabaseLeadScope
- LeadScope Known Drugs DatabasesLeadScope
- LeadScope EnterpriseLeadScope
- LeadScope PersonalLeadScope
- U.S. and Western European In Silico ADME/Tox Products Market June 2006
- DEREK for WindowsLHASA
- METEORLHASA
- VITICLHASA
- iDEABiowisdom/Lion
- LeadNavigatorBiowisdom/Lion
- Pharmotif SolutionsMDS Pharma Services
- GRIDMolecular Discovery Limited
- VolSurfMolecular Discvoery Limited
- MetaSiteMolecular Discovery Limited
- AlmondMolecular Discovery Limited
- ADRIANAMolecular Networks GmbH
- MCASE/MC4
- PCMultiCASE
- CASETOXMultiCASE
- ToxLiteMultiCASE
- METAPCMultiCASE
- MCWEBMultiCASE
- PK-MapNimbus Biotechnology
- CacoReady SoftwareNorayBio
- NorayMet ADMENorayBio
- Metlab ProfilerNovatia
- Partek Screener.s SolutionPartek
- Partek QSAR SolutionPartek
- Partek Discovery SuitePartek
- Algorithm BuilderPharma Algorithms
- QSAR BuilderPharma Algorithms
- ADME Boxes v 3.0Pharma Algorithms
- Tox Boxes v 1.0Pharma Algorithms
- ADME/Tox WEBPharma Algorithms
- DMSO SolubilityPharma Algorithms
- ADME BatchesPharma Algorithms
- AbsolvPharma Algorithms
- PK-SIMBayer Technology Services
- ELM-Evolution Library ManagerpION
- QikPropSchrodinger
- U.S. and Western European In Silico ADME/Tox Products Market June 2006
- ProPhileSupernus Pharmaceuticals
- RADARSupernus Pharmaceuticals
- ProScreenSupernus Pharmaceuticals
- OptiScreenSupernus Pharmaceuticals
- SimcypSimcyp
- ADMET ModelerSimulations Plus, Inc
- ADMET PredictorSimulations Plus, Inc
- Class Pharmer 4.0Simulations Plus, Inc
- GastroPlusSimulations Plus, Inc
- DDDPlusSimulations Plus, Inc
- RefinementPro2Sirius
- DecisionSite for Lead DiscoverySpotfire
- ADMETISStrand Life Sciences
- PK SolutionsSummit PK
- MetabaseSummit PK
- PHYSPROPSyracuse Research Corporation
- TerraQSAR ProgramsTerraBase
- TerraTox Database Products - TerraBase
- Metabolite ID 2.0Thermo Electron Corporation
- SLIPPERTimTec
- DISCONTimTec
- HYBOT-PLUSTimTec
- VolSurfTripos
- SIMCA-P and SIMCA-P + - Umetrics
- MetaboLynx Application ManagerWaters
- Pathways for Adaptive ADME/ToxWhite Carbon
Chapter 4. Market Analysis
- Methodology
- U.S. and European Market Size and Forecast
- U.S. Market Size and Forecast Analysis
- U.S. and Western European In Silico ADME/Tox Products Market June 2006
- European Market Size and Forecast Analysis
- Revenue Analysis
- Competitive Factors